FDA loosens data rules for medical devices by allowing real-world evidence without patient identifiers in marketing submissions.
The FDA’s change opens the door for RWE gleaned from de-identified data sources to be used for device submissions to the ...
FDA is removing barriers to real-world evidence in device applications, allowing the use of de-identified patient data from ...
The Food and Drug Administration recently released finalized guidance for medical device labelers for submitting data to the Global Unique Device Identification Database. A draft version of the ...
According to the FDA’s public database, since the start of this year, the agency has issued only two de novo medical device clearances. That includes the Jan. 17 green light of Myocene’s neuromuscular ...
FDA has amended its database of Recognized Consensus Standards to include revised versions of sterility assurance and sterilization documents previously recognized in December of 2024. The new entry ...
Almost a third of medical device adverse events (AEs) were reported by manufacturers later than the US Food and Drug ...